- Home
- QGEN vs CIB Comparison
QGEN vs CIB Comparison
Compare QGEN & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- CIB
- Stock Information
- Founded
- QGEN 1986
- CIB 1945
- Country
- QGEN Netherlands
- CIB Colombia
- Employees
- QGEN N/A
- CIB N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- CIB Commercial Banks
- Sector
- QGEN Health Care
- CIB Finance
- Exchange
- QGEN Nasdaq
- CIB Nasdaq
- Market Cap
- QGEN 10.8B
- CIB 10.6B
- IPO Year
- QGEN 1996
- CIB 1995
- Fundamental
- Price
- QGEN $48.00
- CIB $46.68
- Analyst Decision
- QGEN Buy
- CIB Hold
- Analyst Count
- QGEN 8
- CIB 5
- Target Price
- QGEN $51.01
- CIB $42.00
- AVG Volume (30 Days)
- QGEN 1.7M
- CIB 264.1K
- Earning Date
- QGEN 08-05-2025
- CIB 08-19-2025
- Dividend Yield
- QGEN 3.18%
- CIB 14.04%
- EPS Growth
- QGEN 405.07
- CIB 10.77
- EPS
- QGEN 1.69
- CIB 1.70
- Revenue
- QGEN $2,040,067,000.00
- CIB $5,707,138,349.00
- Revenue This Year
- QGEN $6.41
- CIB $29.45
- Revenue Next Year
- QGEN $5.70
- CIB $5.88
- P/E Ratio
- QGEN $28.05
- CIB $7.26
- Revenue Growth
- QGEN 5.15
- CIB 10.15
- 52 Week Low
- QGEN $37.63
- CIB $30.57
- 52 Week High
- QGEN $51.88
- CIB $47.78
- Technical
- Relative Strength Index (RSI)
- QGEN 44.29
- CIB 64.93
- Support Level
- QGEN $47.45
- CIB $43.20
- Resistance Level
- QGEN $50.27
- CIB $47.78
- Average True Range (ATR)
- QGEN 0.90
- CIB 1.06
- MACD
- QGEN -0.40
- CIB 0.21
- Stochastic Oscillator
- QGEN 8.80
- CIB 79.48
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About CIB BanColombia S.A.
Grupo Cibest SA formerly BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala. The Bank has the following segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking and All other segments. The majority of revenue is generated from the Banking Colombia segment.